Hydroxyproline-rich glycoprotein promoter

Multicellular living organisms and unmodified parts thereof and – Plant – seedling – plant seed – or plant part – per se

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S419000, C435S320100, C536S024100

Reexamination Certificate

active

08053639

ABSTRACT:
The present invention provides transgenic plants transformed with novel DNA constructs comprising promoter sequences useful for driving the expression of heterologous DNA sequences. Such promoter sequences include promoters hydroxyproline-rich glycoprotein promoters. Also included in the invention are plant cells and seeds produced by the transgenic plants that comprise the novel DNA sequences.

REFERENCES:
patent: 5990387 (1999-11-01), Tomes et al.
patent: 2002/0123118 (2002-09-01), Allen et al.
patent: 2002/0188964 (2002-12-01), Grotewold
patent: 2004/0034888 (2004-02-01), Liu et al.
patent: 2007/0011783 (2007-01-01), Liu et al.
patent: WO 96/29857 (1996-03-01), None
patent: WO 98/30702 (1998-07-01), None
patent: WO 2004/101741 (2004-05-01), None
Tagu et al. (Plant Molecular Biology, 20:529-538, 1992).
Stiefel et al. (GenBank Sequence Accession No. AJ131535, Published Dec. 11, 1998).
Kim et al., (Plant Mol. Biol. 24:105-117, 1994).
Donald et al. (EMBO J. 9:1717-1726, 1990).
Benfey et al., (Science 250:959-966, 1990).
Appendix A (Claims in U.S. Appl. No. 10/839,092 as allowed in Notice of Allowance mailed Mar. 20, 2007). Petition for Withdrawal from Issue under 37 CFR § 1.313(a) for U.S. Appl. No. 10/839,092, filed May 15, 2007.
Appendix B (Claims pending in U.S. Appl. No. 11/520,715) Petition for Withdrawal from issue under 37 CFR § 1.313(a) for U.S. Appl. No. 10/839,092, filed May 15, 2007.
Appendix C (nucleic acid alignment between SEQ ID No. 19 of U.S. Appl. No. 10/839,092 and SEQ ID No. 25824 of U.S. Appl. No. 11/520,715). Petition for Withdrawal from Issue under 37 CFR § 1.313(a) for U.S. Appl. No. 10/839,092, filed May 15, 2007.
Appendix D (amino acid alignment between SEQ ID No. 1 of U.S. Appl. No. 10/839,092 and SEQ ID No. 52139 of U.S. Appl. No. 11/520,715). Petition for Withdrawal from Issue under 37 CFR § 1.313(a) for U.S. Appl. No. 10/839,092, filed May 15, 2007.
EPO Communication EP04751446.8-2406 (PCT/US/2004/014054) European Search Report, dated Aug. 29, 2007.
EPO Communication EP04751446.8-2406 (PCT/US/2004/014054) Supplementary European Search Report, dated Jan. 30, 2008.
GenBank Accession No. AAP54879, Jul. 12, 2006.
Keskin et al., “A new, structurally nonredundant, diverse data set of protein-protein interfaces and its implications,”Protein Science, 13:1043-1055, 2004.
Nuccio et al., “The endogenous choline supply limits glycine betaine synthesis in transgenic tobacco expressing choline monooxygenase,”Plant J., 16:487-496, 1998.
Thornton et al., “From structure to function: approaches and limitations ,”Nature Structural Biology, Structural Genomics Supplement, 7:(11):991-994, Nov. 2000.
Office Action regarding U.S. Appl. No. 10/839,092, dated Aug. 18, 2005.
Response to Office Action regarding U.S. Appl. No. 10/839,092, dated Sep. 16, 2005.
Office Action regarding U.S. Appl. No. 10/839,092, dated Nov. 7, 2005.
Request for Interview with Supervisory Examiner regarding U.S. Appl. No. 10/839,092, dated Feb. 22, 2006.
Interview Summary regarding U.S. Appl. No. 10/839,092, dated Mar. 31, 2006.
Response to Office Action and Amendment regarding U.S. Appl. No. 10/839,092, dated May 2, 2006.
Office Action regarding U.S. Appl. No. 10/839,092, dated Jun. 14, 2006.
Notice of Appeal from the Examiner to the Board of Patent Appeals and Interferences regarding U.S. Appl. No. 10/839,092, dated Sep. 14, 2006.
Amendment After Appeal Under 37 CFR §41.33 regarding U.S. Appl. No. 10/839,092, dated Nov. 10, 2006.
Office Communication—Advisory Action Before the Filing of an Appeal Brief regarding U.S. Appl. No. 10/839,092, dated Nov. 30, 2006.
Appellants' Brief regarding U.S. Appl. No. 10/839,092, dated Dec. 14, 2006.
Petition for Withdrawal from Issue Under 37 CFR § 1.313(a) regarding U.S. Appl. No. 10/839,092, dated May 15, 2007.
Decision on Petition regarding U.S. Appl. No. 10/839,092, dated May 16, 2007.
Office Action regarding U.S. Appl. No. 10/839,092, dated Jul. 11, 2007.
Response to Non-Final Office Action regarding U.S. Appl. No. 10/839,092, dated Jan. 11, 2008.
Notice of Allowance regarding U.S. Appl. No. 10/839,092, dated Mar. 20, 2008.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hydroxyproline-rich glycoprotein promoter does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxyproline-rich glycoprotein promoter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyproline-rich glycoprotein promoter will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4273632

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.